The Scientific Committee begins accepting abstracts and applications for the scientific program of the XI International Forum of Cardiology and Internal Medicine
No Thrombotic Risk From Higher Lp(a) LevelsContrary to indications from previous studies, there is no association between increased lipoprotein(a) concentrations and the risk for subsequent thrombotic events, suggests a new large-scale analysis. (Milan)
Noninvasive Approach to Revascularization Decisions Shows PromiseWhen deciding on the optimal revascularization strategy for patients with multivessel coronary disease, a noninvasive approach using quantitative flow ratio (QFR) showed substantial agreement with the more invasive classical fractional flow reserve (FFR) approach in a new study.
SAFE-PAD Shows Long-Term Safety of Paclitaxel DevicesPatients who have paclitaxel-coated stents and balloons have survival and outcomes comparable to those who have a bare-metal stent or percutaneous transluminal angioplasty, according to updated results from a large study of almost 170,000 Medicare beneficiaries.
ADT for Prostate Cancer: What's the Risk on the Heart?Androgen deprivation therapy (ADT) for localized prostate cancer increases the risk of myocardial infarction (MI), stroke, and other cardiovascular disease (CVD) events as well as death, according to a study from Norway.
RU
EN